Title : DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link?
link : DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link?
DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link?
Abstract
Presented at AASLD The Liver Meeting 2018. Study number 0603.
Kommineni VT et al. Factors Associated with Lack of Improvement in Fibrosis Following HCV Treatment.Monthly Prescribing Reference
DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link?
According to the results of a prospective cohort study, 57% of patients with hepatitis C virus (HCV) infection who achieved sustained virologic response (SVR) showed no improvement in hepatic fibrosis. The study, which took place at a tertiary liver center, aimed to determine whether direct-acting antiviral (DAA) therapy reduced fibrosis and assessed whether any predictors of treatment failure existed at 1-year follow-up. A total of 193 patients were divided into 2 groups: those who achieved SVR (N=143) and those who failed treatment or did not receive it (N=50).
Conference Articles
By Cassandra Pardini, PharmD November 13, 2018
Thus Article DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link?
That's an article DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link? This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link? with the link address https://theleknews.blogspot.com/2018/11/daa-treatment-and-hepatic-fibrosis.html
0 Response to "DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link?"
Post a Comment